Cart
sales@molnova.com
C-021
CAS No. 864289-85-0
C-021( C021 )
Catalog No. M16265 CAS No. 864289-85-0
C-021 is a potent and orally bioavailable CCR4 antagonist with IC50 of 0.14 uM and 0.039 uM for inhibition of chemotaxis in human and mouse, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 59 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 140 | Get Quote |
|
| 25MG | 286 | Get Quote |
|
| 50MG | 444 | Get Quote |
|
| 100MG | 621 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameC-021
-
NoteResearch use only, not for human use.
-
Brief DescriptionC-021 is a potent and orally bioavailable CCR4 antagonist with IC50 of 0.14 uM and 0.039 uM for inhibition of chemotaxis in human and mouse, respectively.
-
DescriptionC-021 is a potent and orally bioavailable CCR4 antagonist with IC50 of 0.14 uM and 0.039 uM for inhibition of chemotaxis in human and mouse, respectively.
-
In Vitro——
-
In VivoAnimal Model:Male C57Bl/6 mice (20-25 g) with acute liver failure.Dosage:1 mg/kg Administration:i.p.; daily; for 3 days Result:Significantly less microgliosis, and significantly reduced the pERK1/2 to tERK1/2 ratio.
-
SynonymsC021
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number864289-85-0
-
Formula Weight467.658
-
Molecular FormulaC27H41N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (106.92 mM)
-
SMILESCOC1=C(C=C2C(=C1)C(=NC(=N2)N3CCC(CC3)N4CCCCC4)NC5CCCCCC5)OC
-
Chemical Name2-([1,4'-bipiperidin]-1'-yl)-N-cycloheptyl-6,7-dimethoxyquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yokoyama K, et al. Bioorg Med Chem. 2009 Jan 1;17(1):64-73.
molnova catalog
related products
-
CXCR2-IN-1
A potent, CNS penetrant CXCR2 antagonist with pIC50 of 9.3; shows neutrophil chemotaxis inhibition with pIC50 of 7.6.
-
BMS-817399
BMS-817399 is a potent, selective, orally bioavailable CCR1 antagonist with binding IC50 of 1 nM, inhibits MIP-1α-induced chemotaxis with IC50 of 6 nM.
-
LIT-927
LIT-927 (LIT927) is the first selective, locally and orally active CXCL12 neutraligand with Ki of 267 nM for CXCL12-TR binding inhibition.
